|
Insider buys
|
2
|
Resverlogix Corp.
|
Nov 29, 2016 04:34PM
|
|
Pfizer buys Seagen for 43 billion
|
2
|
Zenith Epigenetics
|
Mar 13, 2023 08:18PM
|
|
Sophisticated investment group
|
2
|
Resverlogix Corp.
|
May 17, 2021 08:43PM
|
|
Re: Happy Turkey Day...
|
2
|
Resverlogix Corp.
|
Nov 22, 2017 02:43PM
|
|
Re: No word on...
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 10:59AM
|
|
Re: Agm
|
2
|
Resverlogix Corp.
|
Dec 13, 2017 12:48PM
|
|
Re: "ONE of the KEY patents !"
|
2
|
Resverlogix Corp.
|
Mar 15, 2017 11:21AM
|
|
Re: MACE Events - Statistically Confusing
|
2
|
Resverlogix Corp.
|
Mar 01, 2019 02:12PM
|
|
Re: What if RRR MACE is significant at 90% confidence?
|
2
|
Resverlogix Corp.
|
Apr 24, 2018 11:22AM
|
|
Re: Another quarter and not a peep
|
2
|
Resverlogix Corp.
|
Jan 04, 2023 01:06PM
|
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 25, 2023 07:00AM
|
|
Re: 10 Year Anniversary for Resverlogix's Newco !!
|
2
|
Zenith Epigenetics
|
Jan 19, 2023 10:45AM
|
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 24, 2020 03:35PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 07:14AM
|
|
Re: from IR/Chris
|
2
|
Zenith Epigenetics
|
Dec 15, 2022 02:03PM
|
|
Re: Modulating ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
|
2
|
Zenith Epigenetics
|
Sep 02, 2018 12:14PM
|
|
Re: While we are waiting ...
|
2
|
Resverlogix Corp.
|
Feb 11, 2019 09:51PM
|
|
Re: $60m PP Question
|
2
|
Zenith Epigenetics
|
Jan 04, 2018 04:10PM
|
|
AGM DATE NOT RELEASED
|
2
|
Zenith Epigenetics
|
Sep 27, 2017 10:10AM
|
|
Re: Robing Peter to pay Paul
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 10:40AM
|
